Literature DB >> 29790897

Six cycles of R-CHOP-21 are not inferior to eight cycles for treatment of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Population-based Study.

T Wästerlid1, J L Biccler2, P N Brown3, M Bøgsted4, G Enblad5, J Mészáros Jørgensen6, J H Christensen7, B E Wahlin8, K E Smedby9, T C El-Galaly2, M Jerkeman10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29790897     DOI： 10.1093/annonc/mdy184

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  Response-adapted therapy with infusional EPOCH chemotherapy plus rituximab in HIV-associated, B-cell non-Hodgkin's lymphoma.

Authors:  Joseph A Sparano; Jeannette Y Lee; Lawrence D Kaplan; Juan Carlos Ramos; Richard F Ambinder; William Wachsman; David Aboulafia; Ariela Noy; David H Henry; Lee Ratner; Ethel Cesarman; Amy Chadburn; Ronald Mitsuyasu
Journal:  Haematologica       Date:  2021-03-01       Impact factor: 9.941

2.  A Multicenter Study of 239 Patients Aged Over 70 Years With Diffuse Large B-Cell Lymphoma in China.

Authors:  Chunli Yang; Qiaoer Li; Ke Xie; Yakun Zhang; Dania Xiang; Yunwei Han; Liqun Zou
Journal:  Front Pharmacol       Date:  2022-07-18       Impact factor: 5.988

Review 3.  DLBCL 1L-What to Expect beyond R-CHOP?

Authors:  Maike Stegemann; Sophy Denker; Clemens A Schmitt
Journal:  Cancers (Basel)       Date:  2022-03-11       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.